News & Publications2020-09-28T15:31:35+00:00
Load More Posts


One of AnaBio’s greatest achievements involves the development of cost efficient microencapsulation systems using natural, food-grade, low-cost materials with no artificial additives, excipients or agents. Hence, AnaBio provides specialist bespoke scientific ‘know-how’ and novel ingredient delivery systems for industry clients seeking to access new markets or planning product upgrades. The key focus at AnaBio is improving functional ingredients for example, ensuring stability in probiotics and vitamins for uses in functional foods and beverages but also focusing on imrpoving the tastes of ingredients such as caffeine and vitamin C for use in sports nutrition gels and gummies. At present, AnaBio is working with milk and vegetable proteins, hydrocolloids, fibres, prebiotics and plant extracts to generate innovative capsule systems. To date, AnaBio has formulated patented encapsulation systems using UHT milk, proteins (vegetable and dairy), citrus fibres, prebiotics, pectins, carrageenans and alginate mixtures. See our home, products and intellectual property pages for further information on what we do and the benefits and success of AnaBio’s microencapsulation technologies.

Awards & Nominations

Emerging Company of the Year 2014
Bank of Ireland IGNITE Company of the Year 2013
Outstanding Person of the Year 2013
Cork Person of the Month (August) 2013
Finalist for Emerging Company of the Year 2013
Finalist for Cork Person of the Year 2013

Publications & Links


Doherty, S.B., Gee, V.L., Ross, R.P., Stanton, C., Fitzgerald, G.F., and Brodkorb, A., 2010. Efficacy of whey protein gel networks as potential viability-enhancing scaffolds for cell immobilization of Lactobacillus rhamnosus GG. Journal of Microbiological Methods. 80, 231-241.

Doherty, S.B., Wang, L., Ross, R.P., Stanton, C., Fitzgerald, G.F., Brodkorb, A., 2010a. Use of viability staining in combination with Flow Cytometry for rapid viability assessment of Lactobacillus rhamnosus GG in complex protein matrices. Journal of Microbiological Methods. 82, 301-310.

Doherty, Auty, M.A., Ross, R.P., Stanton, C., Fitzgerald, G.F., Brodkorb, A., 2011a. Development and characterisation of whey protein micro-beads as potential matrices for probiotic protection. Food Hydrocolloids 25, 1604-1617.

Doherty, S.B., Auty, M.A., Stanton, C., Ross, R.P., Fitzgerald, G.F., Brodkorb, 2011b. Survival of entrapped Lactobacillus rhamnosus GG in whey protein micro-beads during simulated ex vivo gastro-intestinal transit. International Dairy Journal, In Press (September 2011).

Doherty, S.B., Upadrasta, A., Lawlor, P.G., Ross, R.P., Stanton, C., Fitzgerald, G.F., Brodkorb, A., 2011c. Evaluation of whey protein micro-bead transit time in the porcine gastro-intestinal tract, Journal of Microencapsulation, Published, October 2011.

Doherty, S.B., Auty, M.A., Ross, R.P., Stanton, C., Fitzgerald, G.F., Brodkorb, A., 2011d. Application of whey protein micro-bead coatings for enhanced strength and probiotic protection during fruit juice storage and gastric incubation, Journal of Micriencapsulation, Published, October, 2011.

Doherty, S.B., Upadrasta, A., Auty, M.A.E., Lawlor, P.G., Walsh, M.C., Ross, R.P., Stanton, C., Fitzgerald, G.F. and Brodkorb, A. (2011e). Application of whey protein micro-beads for improved probiotic delivery and functionality during in vivo gastro- intestinal transit, Published, November 2014

Heade J., Bleiel S.B., Brayden D.J., (2016), “Overcoming the obstacles associated with oral delivery of peptides” Engineers Journal.

Pre/probiotic encapsulation technology for novel infant and toddler formulations. (Presentation) Probiota 2014, Amsterdam, The Netherlands, 4-5th February 2014.

Kent R.M., Stack H.M., O’Connor P.M., Fitzgerald G.F., Hill C., Stanton C., Ross R.P. Enzymatic production of casein-derived bioactive peptides; In silico prediction to pilot scale. Submission in progress

Guinane C.M., Kent R.M., O’Connor P.M., Fitzgerald G.F., Hill C., Stanton C., Ross R.P. Recombinant Lactobacillus paracasei strain producing active gut hormone Glucagon-like peptide-1 (GLP-1). Submission in progress

Heade J., Maher S., Bleiel S.B., Brayden D.J., (2018), “Labrasol® and salts of medium chain fatty acids can be combined in low concentrations to increase the permeability of a macromolecule marker across isolated rat intestinal mucosae” J. Pharm. Sci. (under review)

Guinane C.M., Kent R.M., Norberg S., Hill C., Fitzgerald G.F., Stanton C., Ross R.P.Host specific diversity in Lactobacillus johnsonii as evidenced by a major chromosomal inversion and phage resistance mechanisms. PLoS One. 2011 Apr 20;6(4):e18740.

Guinane C.M., Kent R.M., Hill C., Fitzgerald G.F., Stanton C., Ross R.P Genomic rearrangements in the intestinal bacterium Lactobacillus johnsonii. (Poster presentation) US/Ireland Functional Foods Conference 2010, Cork, Ireland.

RM Kent, SB Doherty:  Probiotic bacteria in infant formula and follow-up formula: Microencapsulation using milk and pea proteins to improve microbiological quality

– Food research international, 2014 – Elsevier

Alleleyn, A.M.E.; Van Avesaat, M.; Ripken, D.; Bleiel, S.B.; Keszthelyi, D.; Wilms, E.; Troost, F.J.; Hendriks, H.F.J.; Masclee, A.A.M. The Effect of an Encapsulated Nutrient Mixture on Food Intake and Satiety: A Double-Blind Randomized Cross-Over Proof of Concept Study. Nutrients 201810, 1787. DOI:

Hone, M., Kent, R.M., Scotto di Palumbo, A., Bleiel, S.B., De Vito, V., & Egan, B., (2017). Plasma Creatine Kinetics After Ingestion of Microencapsulated Creatine Monohydrate with Enhanced Stability in Aqueous Solutions, Journal of Dietary Supplements, 14:4, 433-445, DOI: 10.1080/19390211.2016.1267060

Go to Top